Hemoglobin A1c Testing Devices and Kits Market

Report Code: MDS095A

Publish Date: Oct 2023

Publisher: BCC Publishing

Category: Medical Devices And Surgical

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.

Report Includes

  • 131 data tables and 46 additional tables
  • An overview of the global market landscape related to the hemoglobin A1c testing devices and kits
  • In-depth analysis of global market trends, featuring historical revenue data for 2020- 2022, estimated figures for 2023, as well as forecasts for 2023-2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to hemoglobin A1c testing devices and kits, accompanied by a comprehensive market share analysis categorized by technology, end user, and geographical region
  • Understanding of the upcoming market potential for hemoglobin A1c test devices and kits, and areas of focus to forecast this market into various segments and sub-segments
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, regulations, prospects, and contributions to the overall market
  • Discussion of the role and importance of ESG in HbA1c test devices and kits market, consumer attitudes, risks and opportunity assessment, and ESG practices in the industry
  • Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
  • Detailed profiles of leading market participants including Abbott, Siemens Healthineers, Bayer AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc., providing a descriptive overview of their respective businesses

Report Scope

This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.

This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.

Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $1.9 billion
Market size forecast $3.2 billion
Growth rate CAGR of 9.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Technology, End-User, Region, and Country
Regions covered North America, Europe, Asia-Pacific, and Rest of World
Countries covered U.S., Canada, Mexico, France, Germany, U.K., Italy, Spain, China, India, Australia & New Zealand, Japan, GCC countries, and Brazil
Key Market Drivers
  • Incidence and Prevalence of Diabetes
  • Next Generation of Type 2 Diabetes Treatment
  • Growing Recognition and Awareness of Diabetes as a Global Epidemic
Companies studied
ABBOTTARKRAY INC.
BAYER AGBIO-RAD LABORATORIES INC.
DANAHER CORP.EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.LUMIRADX
MERIL LIFE SCIENCES PVT. LTD.OSANG HEALTHCARE CO. LTD.
SIEMENS HEALTHINEERS AGSINOCARE INC.
THERMO FISHER SCIENTIFIC INC.TRINITY BIOTECH PLC
WUXI BIOHERMES BIOMEDICAL TECHNOLOGY CO. LTD.XIAMEN BIOTIME BIOTECHNOLOGY CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The market is projected to grow from $1.9 billion in 2022 to $3.2 billion in 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period.
The key factors driving the growth of the HbA1c Testing Devices & Kits market include increasing adoption of HbA1c testing kits, Incidence of HbA1c test in Point of care units increasing and growing awareness programs.
The HbA1c Testing Devices & Kits market is segmented based on technology type, and end user and region.
By Technology type, chromatography and Assay technique segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.
  • F. Hoffmann-La Roche AG
  • Abbott
  • Siemens Healthcare GmbH
  • Danaher
  • Bayers AG
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Hemoglobin A1c Testing Devices and Kits Market282Free
Chapter- 1: Introduction10Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview14Free
Chapter- 4: Market Dynamics15Free
Chapter- 5: Global Market for Hemoglobin A1c Testing Devices and Kits by Technology9Free
Chapter- 6: Global Market for Hemoglobin A1c Testing Devices and Kits by End User6Free
Chapter- 7: Global Market for Hemoglobin A1c Testing Devices and Kits by Region121Free
Chapter- 8: Sustainability in the Hemoglobin A1c Testing Devices and Kits Industry: An ESG Perspective13Free
Chapter- 9: Emerging Technology in the Diabetes Diagnosis Industry: Qualitative Perspective6Free
Chapter- 10: M&A and Venture Funding Outlook in the Market22Free
Chapter- 11: Competitive Landscape4Free
Chapter- 12: Company Profiles55Free
Chapter- 13: Appendix3Free

Related Reports

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Sep 2023 | Publisher - Bejini Sandeep Kumar | Code - HLC029F

The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC102D

The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.

Global Diabetic Care Devices Market

Published - Oct 2020 | Publisher - BCC Publishing | Code - MDS019A

The global market for diabetes monitoring devices should grow from $19.7 billion in 2020 to $27.0 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.

Blood Testing: Technologies and Global Markets

Published - Nov 2018 | Publisher - BCC Publishing | Code - HLC184B

The global market for blood testing will grow from nearly $53.8 billion in 2018 to $60.5 billion by 2023 with a compound annual growth rate (CAGR) of 2.4% for the period of 2018-2023.

Recent Reports

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Published - Nov 2024 | Publisher - Gundreddy Gopinadh | Code - MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Global Medical Tapes Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - MDS105A

The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.

Global Prenatal Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Global Skin Allergy Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS104A

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Hemoglobin A1c Testing Devices and Kits Market
Sample Report